Lupin gets US health regulator's approval for asthmatic symptoms prevention drug

The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hsl0vN
via IFTTT